Social Media Use During COVID-19

Depression Clinical Trial

Official title:

Getting it Right: Towards Responsible Social Media Use During a Pandemic

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04305574
• Other study ID #: 2020-CERC-001
• Status: Completed
• Start date: March 7, 2020
• Est. completion date: April 21, 2020

Study information

• Verified date: July 2020
• Source: Yale-NUS College
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The investigators plan to conduct a cross-sectional survey to examine how social media use during COVID-19 relates to: (1) information management, (2) assessment of the situation, and (3) affect.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1145
• Est. completion date: April 21, 2020
• Est. primary completion date: April 21, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 21 Years and older

Eligibility

Inclusion Criteria:

• At least 21 years

• Has stayed in Singapore for at least 2 years

Exclusion Criteria:

• Below 21 years

• Has stayed in Singapore for less than 2 years

Related Conditions & MeSH terms

• Anxiety
• Coronavirus
• Coronavirus Infections
• Depression
• Stress

Intervention

Behavioral:
• Use of social media during COVID-19
Participants' self-reported use of an official WhatsApp channel to receive and share news about COVID-19

Locations

Country	Name	City	State
Singapore	Yale-NUS College	Singapore

Sponsors (1)

Lead Sponsor	Collaborator
Jean Liu

Country where clinical trial is conducted

Singapore, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Assessment of COVID-19 situation	3 items on fear of the situation, confidence the government can manage the situation, and assessed chance of being infected (each rated using 4-point scales: min = 1, max = 4; higher scores indicate increased confidence / likelihood / fear)	Single measurement (upon study enrolment)
Other	Familiarity and trust in COVID-related rumours	Participants' self-report of their familiarity (yes/no) and belief of specific (yes/no), and whether they shared these on social media (yes/no)	Single measurement (upon study enrolment)
Primary	Depression, Anxiety and Stress Scale	21-item validated scale assessing symptoms of depression, anxiety, and stress (DASS-21): Min score = 0, Max score = 21; higher score indicates a worse outcome	Single measurement (upon study enrolment)